Objectives: To investigate the function of penicillin-binding protein 2 (PBP 2) in Pseudomonas aeruginosa PAO1.
Introduction
Penicillin-binding proteins (PBPs) are essential for the growth and division of bacterial cells because they catalyse the final stages of peptidoglycan biosynthesis within the periplasm. 1 -4 They belong to the family of acyl serine transferases and they are broadly classified according to their molecular size as either high-molecular-weight (HMW) or low-molecular-weight (LMW) PBPs. 5 All are associated with the outer leaflet of the cytoplasmic membrane, and all possess a penicillin-binding (PB) domain. The PB domain, which contains the catalytic serine residue, functions to catalyse either the transpeptidation (HMW-PBPs) or hydrolysis (LMW-PBPs) of the stem peptides associated with the muramoyl residues of the newly incorporated peptidoglycan subunits. The HMW-PBPs are further characterized by an N-terminal, non-penicillin binding (n-PB) domain which is anchored to the cytoplasmic membrane via a non-cleavable signal-sequence peptide. In some cases, the n-PB domain also catalyses the transglycosylation of bactoprenol-linked precursors into the growing peptidoglycan sacculus. These latter proteins are thus both multi-modular and bi-functional, and they have been classified as class A HMW-PBPs. The class B HMW-PBPs possess an N-terminal domain, but it does not appear to catalyse transglycosylase activity. For these HMW-PBPs, it has been suggested that the n-PB domain plays a role in directing the proper folding of the C-terminal PB domain and/or is involved in protein -protein interactions. 6 -8 In Escherichia coli, there are 13 known PBPs; three class A (PBPs 1a, 1b and 1c) and two class B (PBPs 2 and 3) HMW-PBPs, and eight LMW-PBPs (PBPs 4, 5, 6, 7 and 8, DacD, AmpC and AmpH). 9 Inhibition experiments with mecillinam, a b-lactam with specificity for PBP 2 (reviewed in ref. 10) , and in vitro deletion studies targeting the gene encoding PBP 2 11 -13 have shown that cells grow as enlarged spheres in the absence of this protein's activity suggesting that it functions in the maintenance of the rod shape of this bacterium. Upon continued exposure to mecillinam for 2 h or more, E. coli cells begin to lyse due to a blockage in cell division. 14, 15 In contrast, cells of the opportunistic pathogen Pseudomonas aeruginosa seem to be able to tolerate exposure to mecillinam and are viable in the presence of up to at least 400 mg/L. 16, 17 Using the conventional PBP assay, which involves SDS-PAGE analysis of proteins treated with radiolabelled penicillin and autoradiography, 18 an earlier study suggested that P. aeruginosa produces six PBPs. 17 Based on apparent molecular masses, these were proposed to be homologues of E. coli PBPs 1a, 1b, 2, 3, 4 and 5. Subsequently, the genes encoding PBPs 1a, 19 3, 20 a second form of 3 named 3x 21 and 5 22 were cloned and characterized. In addition, the product of P. aeruginosa gene pbpG was shown to be a homologue of E. coli PBP 7, a DD-endopeptidase. 23 Nothing else has been reported to date confirming the existence of other PBPs, including PBP 2, in this pathogen.
Given the importance of the b-lactam antibiotics to combat bacterial infections over the past sixty years, a considerable amount of information is known about the structure and function relationship of the PB domain of the PBPs. However, the emergence of a number of b-lactam-resistant pathogens has posed serious threats to the continued efficacy of this important class of antibiotics. In efforts to develop new therapeutic strategies, attention has been drawn to the n-PB domain of the HMW PBPs (e.g. ref. 24) about which little is currently known (reviewed in ref. 25) . The determination of the three-dimensional structures at high resolution of the class B PBPs 2x from Streptococcus pneumoniae (PDB: 1QMF) 26 and 2a from an MRSA strain of Staphylococcus aureus (PDB: 1VQQ) 27 will greatly facilitate investigations of these enzymes, but enzymological studies are still lacking.
To further our understanding of the organization, activity and function of the class B PBPs, we have initiated studies with the enzymes of P. aeruginosa. Here, we investigate the effects of mecillinam on the growth and morphology of P. aeruginosa and describe the cloning and overexpression of the P. aeruginosa gene encoding PBP 2, pbpA, in both its native membrane-bound form and a genetically-engineered soluble form. We also describe the generation and phenotype of a mutant lacking a functional pbpA gene.
Materials and methods

Plasmids, bacterial strains and growth conditions
All plasmids used or constructed, together with bacterial strains used in this study are listed in Table 1 . Cultures were routinely grown in Luria-Bertani (LB) broth [1% tryptone (Difco, Detroit, MI, USA), 0.5% yeast extract (Difco) and 0.5% NaCl] at 378C with agitation. For overexpression of cloned genes, cultures were grown in rich medium containing 3.2% tryptone, 2% yeast extract and 1% NaCl. Strains harbouring resistance determinants were grown in the presence of ampicillin (100 mg/L), kanamycin (50 mg/L), chloramphenicol (34 mg/L) and/or tetracycline (15 mg/L for E. coli, 110 mg/L for P. aeruginosa). Unless otherwise stated, all reagents and chemicals were obtained from Sigma-Aldrich Canada Ltd., Oakville, ON, Canada.
Determination of MICs
The MIC values for the b-lactams mecillinam (Leo Pharmaceutical Products, Denmark), ampicillin, amoxicillin, carbenicillin, cefotaxime, cefoxitin, cefalotin and ticarcillin for P. aeruginosa PAO1 and E. coli DH5a were determined using LB broth containing doubling concentrations of the penicillin at 378C with shaking at 200 rpm. MICs were defined as the lowest concentration of compound to inhibit visible growth after 18 h incubation.
Growth curves and viable counts
The growth characteristics of the E. coli and P. aeruginosa in the absence and presence of mecillinam were determined by incubating a 1/20 dilution of overnight cultures in 50 mL of LB containing the appropriate amount of mecillinam at 378C with shaking (200 rpm). Growth of the cultures, in triplicate, was monitored by both OD 600 and viable counts for at least 6 h. For viable counts, samples of the growing cultures were serially diluted in sterile saline (10 22 , 10 23 , 10 24 , 10 26 , 10 28 ) and 100 mL aliquots were plated onto LB plates containing 5% agar (Difco). After 16 h incubation at 378C, the colonies were counted and viable counts determined.
Scanning EM
Bacterial cell pellets were washed and resuspended in 0.07 M Sorensen's phosphate buffer, pH 6.8 (PBS), placed on a 13 mm carbon planchette (Canemoc & Marivac, Lakefield, Quebec, Canada) and fixed with 2% gluteraldehyde in PBS buffer for 1 h. The samples were then rinsed in several changes of buffer, dehydrated through a series of ethanol washes, critical point dried using carbon dioxide, and sputter coated with 20 nm of gold/palladium in a Hummer VII sputter coater (Anatech Corp. Alexandria, VA, USA). To visualize the bacteria, filters were scanned using a Hitachi S-570 SEM (Tokyo, Japan), and images were collected directly from the SEM using Quartz PCI software (Quartz Imaging Corp. Vancouver, BC, Canada).
Cloning and genetic engineering of pbpA P. aeruginosa chromosomal DNA from strain PAO1 was prepared from an overnight culture using DNAzol (Invitrogen Canada Inc., Burlington, ON, Canada), according to the manufacturer's protocol. The isolated DNA was used to PCR amplify pbpA encoding PBP 2 using the Expand PCR kit (Roche Molecular Biochemicals, Laval, QC, Canada) according to the manufacturer's instructions. The oligonucleotide primers used were 5 0 -CCAGTCCATATGCCGCAGACCATCCACCTG-3 0 (NdeI) and 5 0 -GCGGTCGAAGCTTCTGTTCAAGGGCGGGCG-3 0 (HindIII). NdeI and HindIII restriction sites were used to facilitate the cloning into the vectors pGEM-T (Promega) and pET30a(þ) (Novagen, Madison, WI, USA) to provide pACJW1 and pACJW2, respectively. In addition, the pET30a(þ) construct was designed to express the full-length PBP 2 as a fusion with a C-terminal hexa-His tag To facilitate its expression and purification, a truncated construct of pbpA was engineered by removing the 5 0 sequence coding for the hydrophobic leader peptide (amino acids 1 to 38) of PBP 2 ( Figure 1 ). The open reading frame encoding PBP 2 starting at amino acid 39 (methionine) was PCR amplified as described above using the following oligonucleotide primers: 5 0 -TGGTGGCGCATATGTACCACCTG-3 0 (NdeI) and 5 0 -GCGGTCGAAGCTTCTGTTCAAGGG-3 0 (HindIII). The truncated pbpA was cloned into pET30a(þ) yielding pACKD16 thereby encoding the truncated protein with a hexa-His tag. The nucleotide sequences of each of the constructs were confirmed prior to protein expression experiments.
Site-specific replacement of Ser-327 in the full-length PBP 2 with an Ala residue was performed using the QuickChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) resulting in construct pACDC38. The following primers were used for this procedure using the recommended protocol given by Stratagene: 5 0 -CTATCCTCCGGGCGCGACGGTGAAGCCG-3 0 and 5 0 -CGGCTTCACCGTCGCGCCCGGAGGATAG-3 0 .
Expression and purification of PBP 2 E. coli BL21(lDE3) codon plus ( pLysS) harbouring either pET30a(þ), pACJW2 or pACKD16 were grown in 1 L of rich medium at 378C with agitation. To induce protein expression, 1 mM IPTG (Roche) was added to the culture when it reached an OD 600 of 0.6, and growth was continued for a maximum of 3 h. The cells were harvested by centrifugation (6000 g, 15 min, 48C), and re-suspended in either 10 mM Tris-HCl pH 8.0, containing 10 mM MgCl 2 and Complete Mini, EDTA-free Protease Inhibitor Cocktail Tablets (Roche) for cell fractionation to obtain membrane-associated PBP 2-His 6 , or lysis buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, 10 mM imidazole, pH 8.0 containing Complete Mini, EDTA-free Protease Inhibitor Cocktail Tablets) for direct purification of sPBP 2-His 6 . For the isolation of membrane-bound PBP 2, the cell suspension was lysed by passage through a French Pressure Cell Press (American Instrument Co., Silver Spring, MD, USA). Unlysed cells were removed by centrifugation (6000 g, 10 min) and the membrane fraction was recovered by ultracentrifugation (100 000 g, 60 min, 48C). This isolated membrane fraction was resuspended in 20 mM Tris-HCl, pH 8.0, containing 2% N-lauryl-sarcosine, stirred for 12 h at 48C, and then unsolubilized matter was removed by ultracentrifugation (100 000 g, 60 min, 48C). The membrane extract was diluted to 1% Sarkosyl with 200 mM sodium phosphate, 30 mM Tris buffer, pH 8.0, containing 1 M NaCl, 20% glycerol and subjected to affinity chromatography on His-Select Nickel Affinity Gel (Sigma) at 48C. The resin was washed with 250 mL of wash buffer (100 mM sodium phosphate, 15 mM Tris, pH 8.0, containing 0.5 M NaCl, 10% glycerol and 0.5% Sarkosyl) and the bound PBP 2 was eluted with 2Â 1 mL volumes of wash buffer containing 250 mM imidazole.
For isolation and purification of sPBP 2, the cell suspension in lysis buffer was passed through a French Press and un-lysed cells and other particulates were removed by centrifugation (8000 g, 10 min, 48C). The cell lysate was added to 1 mL His-Select agarose, previously equilibrated in lysis buffer. After gentle agitation for 1 h at 48C, the slurry was transferred to a 25 mL column and washed with 100 mL of lysis buffer containing 20 mM imidazole, followed by 100 mL of lysis buffer containing 30 mM imidazole. sPBP 2-His 6 was eluted from the column with 6 mL lysis buffer containing 250 mM imidazole.
Western immunoblotting
Detection of expressed PBP 2 took advantage of the fusion of the C-terminal His 6 -tag and a commercially available mouse anti-His antibody ('His Probe H-3' from Santa Cruz Figure 1 . Amino acid sequence alignment of E. coli PBP 2 with hypothetical sequence encoded by P. aeruginosa pbpA. The predicted inside to outside transmembrane helix (residues 19-37) and the SxxK consensus sequence involving the catalytic Ser-327 residue are enclosed within the boxes, while the sequences determined for the purified PBP 2-His 6 and sPBP 2-His 6 by N-terminal amino acid sequencing are underlined by the horizontal arrows.
Biotechnology, Santa Cruz, CA, USA). Western immunoblotting was performed as previously described. 28 
PBP assay
PBP 2-His 6 and sPBP 2-His 6 were analysed for penicillinbinding activity by the SDS-PAGE-based assay using fluorescent Bocillin FL (Molecular Probes Inc., Eugene, OR, USA) 29 and biotinylated ampicillin. 30 For the fluorescent PBP assays, 19 mL samples of the purified protein ($5 mg) were incubated with 5 mL of Bocillin (final concentration of 50 mM) for 2 h at 358C. SDS-PAGE sample buffer was added to protein samples and boiled for 10 min prior to electrophoresis. Detection of PBPpenicillin complexes was achieved by exposure of the gel to UV 290nm light.
The biotinylated ampicillin PBP assays were adapted from the protocols of Dargis and Malouin 30 and Okamoto et al. 31 To prepare biotinylated ampicillin, NHS-biotin was added at a 5:1 ratio to 110 mg/L of ampicillin in 100 mM sodium phosphate buffer, pH 7.2 and incubated at room temperature for 30 min. To block any unreacted NHS-biotin, a ten-fold molar excess of glycine was added and incubated for an additional 30 min. To label and detect PBPs, typically 5 mL of the biotin-ampicillin was added to 19 mL of PBP sample (2-10 mg) and incubated at 358C for 2-3 h. The reaction was stopped by adding 6 mL of SDS-PAGE sample buffer and boiling for 3 min. Following electrophoresis in a 12.5% SDS-PAGE gel, the separated proteins were transferred to a nitrocellulose membrane, blocked with 3% BSA, and washed as previously described. 28 A 1:50 000 dilution of streptavidin-HRP (Pierce) in blocking buffer was applied to the membrane and allowed to bind to biotin-ampicillin-PBP complexes for 1 h at room temperature. To remove unbound streptavidin conjugates, the membrane was washed several times in TTBS at 378C. The membrane was incubated in HRP substrate (SuperSignal West Femto Maximum Sensitivity Substrate; Pierce) for 5 min. Excess reagent was drained and the membrane was exposed to Bioflex MSI film (Clonex, Markham) and developed.
Mecillinam competition assay
Equivalent protein samples (5-10 mg) were pre-incubated with 5 mL of either mecillinam (1, 5, 10, 50, 500 and 1000 mg/L, final concentrations) or water (as the control) for 30 min at 358C before applying either fluorescent Bocillin FL or biotinylated ampicillin for incubation in a PBP assay.
MALDI-TOF MS fingerprinting
The protocol used was that recommended by the Biological Mass Spectrometry Facility at the University of Guelph, modified from the procedure by Shevchenko et al. 32 Briefly, the protein was subjected to SDS-PAGE. The separating gel was fixed for 30 min in 5:4:1 methanol:H 2 O:acetic acid and then stained for 30 min in Coomassie Brilliant Blue R. The band of interest was excised from the gel, diced and washed three times for 5 min by vortexing in H 2 O. To destain, 100 mL of 50 mM NH 4 HCO 3 in 50% acetonitrile was added and the suspension was vortexed for 10 min. The gel particles were dried with 100 mL of acetonitrile. Reduction and alkylation of cystine groups was not performed because PBP 2 is not predicted to have any cysteine residues. Sequencing grade trypsin (Sigma) was added to the gel particles in 50 mL of 100 mM NH 4 HCO 3 and the digesting mixture was incubated 378C overnight. The resulting digest was spotted onto a MALDI sample plate and was analysed on a Bruker Reflex III MALDI-TOF in reflectron mode using a 337 nm nitrogen laser set to 109 -121 mJ output. Analysis of peptides was done using the on-line tool MS-Fit (http://prospector.ucsf.edu).
Analysis of peptidoglycan cross-linking
Cultures of each of the strains were grown in LB at 378C with shaking for 3 to 5 h until mid-exponential phase (OD 600 of 0.60 to 0.90). Cells were harvested by centrifugation at 8000 g for 15 min and washed twice in 10 mM sodium phosphate pH 7.0. Insoluble peptidoglycan was extracted from whole cells by boiling in 4% SDS procedure as previously described. 33 Peptidoglycan insoluble in 4% SDS was collected by ultracentrifugation at 100 000 g for 60 min at 208C. The pellet was washed with water several times. This peptidoglycan was further purified by treatment with a-amylase, DNase, RNase and pronase as described previously. 33 Analysis of peptidoglycan cross-linking associated with the different P. aeruginosa transformants was accomplished using the HPLC-based method of Glauner 34 following the digestion of isolated peptidoglycan with 20 U/mL mutanolysin at 378C for 16 h. The digested material was subjected to centrifugation (12 000 g, 10 min, RT) to remove any remaining insoluble material, and the soluble muropeptides in the supernatants were reduced with sodium borohydride in 0.5 M sodium borate buffer, pH 9, before being applied to a 4.6 Â 250 mm Gemini C18 (5 m) analytical column (Phenomenex Inc., Torrance, CA, USA). Detection of eluting muropeptides was achieved by monitoring A 205 .
Generation of a pbpA chromosomal insertion mutant
A gene replacement strategy for making chromosomal knockout mutants in P. aeruginosa was employed. 35 The oligonucleotide primers used to amplify pbpA and flanking regions were 5 0 -CCGCTCTAGAAGGTCGGCCCTGGAG-3 0 (XbaI) and 5 0 -CCCTAAGCTTCGTGGCCGATCAC-3 0 (HindIII). The amplified DNA was ligated into the suicide vector pEX18Ap to produce the plasmid pACBL13. This plasmid was transformed into the E. coli strain SCS110 (lacking Dam methylation on DNA). pACBL13 was isolated from this strain and subsequently digested with the restriction enzyme BclI (which is unable to digest Dam methylated DNA). A non-polar 1088 bp Gm R cassette was obtained from the plasmid pPS856 by digestion with BamHI. Since BclI and BamHI create compatible sticky ends, the Gm R cassette was inserted within the pbpA gene located on pACBL13 to create plasmid pACBL15. pACBL15 was transformed into the E. coli mobilizer strain SM10, and transferred to P. aeruginosa PAO1 via conjugation using a modification of the method by Simon et al. 36 Briefly, E. coli SM10 ( pACBL15) and P. aeruginosa PAO1 were grown until late exponential stage. The two cell lines were combined in varying ratios (1:9, 9:1 and 1:1), centrifuged to concentrate, and then spotted onto pre-warmed LB plates and incubated overnight at 378C. P. aeruginosa conjugants were selected by resuspending spotted cells in LB and plating on Pseudomonas Isolation Agar with 150 mg/L gentamicin. The pEX18Ap vector contains the Bacillus subtilis sacB gene, and when expressed makes cells sensitive to sucrose. Thus, streaking cells on a 10% sucrose medium containing 150 mg/L gentamicin inhibited the growth of merodiploids and selected for true recombinants. Colonies that could grow on this medium and were also carbenicillin susceptible (600 mg/L) were further screened by PCR using the primers 5 0 -CTACCACAAATAGTCCCCAGTCCCG-3 0 and 5 0 -GTCTTCGTTGGACAGGGTGCGGTCG-3 0 to verify insertion of the Gm R cassette.
Construction of the pbpA complementation vectors
The pbpA gene together with an upstream ribosome-binding site, but lacking the histidine tag was subcloned from the pET construct pACJW2 using PCR with the primers 5 0 -GAGCGGATAACAATTCCCCTCTAGA-3 0 (XbaI) and 5 0 -GAGTGCGGCCGAATTCTACTGTTCAAGG-3 0 (EcoR1). After PCR amplification, the product was ligated into the complementation vector pUCP26 37 resulting in construct pACBL31. Cloning was performed in E. coli DH5a using repressing conditions (0.2% glucose) and using medium adjusted to pH 5.0 to minimize the lethality of PBP 2 expressed in E. coli. A derivative of pACBL31 (named pACBL34) was engineered using the QuickChange Site-Directed Mutagenesis Kit and the primers described above to encode the Ser-327 ! Ala PBP 2 derivative. Electrocompetent cells of P. aeruginosa for transformation with pACBL31 and pACBL34 were prepared using the method of Choi et al.
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Other analytical techniques were determined using a commercial BCA assay (Pierce, Rockford, IL, USA) with BSA (0.05 -2 mg/mL) as the standard. The assay was performed according to the procedure outlined by the manufacturer except the absorbance was measured at 595 nm rather than 560 nm. N-terminal sequence analysis of purified PBP 2-His 6 and sPBP 2-His 6 that were subjected to SDS-PAGE and subsequently transferred to 0.45 mm polyvinylidene difluoride membrane was performed by David Watson, National Research Council, Ottawa, Canada.
Results
Effect of mecillinam on growth and morphology in P. aeruginosa
The effects of the b-lactam antibiotic mecillinam on growth of P. aeruginosa and E. coli in LB at 378C were determined by monitoring both turbidity at 600 nm and viable cell counts. As seen in Figure 2 , the addition of 10 mg/L mecillinam to cultures of E. coli caused a cessation of growth and following a short stationary phase, the cells entered into a death phase with concomitant cell lysis. In contrast, cultures of P. aeruginosa remained viable in concentrations of mecillinam as high as 400 mg/L and they continued to grow at approximately the same rate as untreated cells. An attempt was made to determine the MIC of mecillinam for P. aeruginosa PAO1 growth in LB broth. Under the conditions employed, concentrations as high as 2000 mg/L did not prevent growth while the MIC of this b-lactam for E. coli DH5a was determined to be 1.0 mg/L. These data are thus consistent with those previously documented by others where MICs for strains of E. coli were found to be 1.0 mg/L while P. aeruginosa is reported to be resistant to mecillinam. 10, 16 Despite the fact that mecillinam did not appear to inhibit growth of P. aeruginosa, cells cultured in its presence were nonetheless examined by SEM. When treated with 10 mg/L mecillinam (i.e. 10Â MIC) E. coli formed enlarged spherical cells within 1.5 to 2 h of antibiotic addition (Figure 2) . These spheres were, on average, approximately 1.7 mm in diameter. As expected, evidence of cell lysis was observed after prolonged incubation. With P. aeruginosa at this concentration of mecillinam, cells retained their normal rod shape but, surprisingly, a morphological change to spherical cells was observed when incubated at concentrations between 200 mg/L and 400 mg/L (Figure 2) . Unlike E. coli, however, these spherical cells were not enlarged but rather retained the same diameter of approximately 0.5-0.7 mm as their former rod shape. Also, in contrast to E. coli, removal of the antibiotic by harvesting the cells, washing with PBS, and re-suspending them in fresh LB broth resulted in their reversion back to their original rod shape. No such reversion was observed with E. coli. Thus, while mecillinam causes the same morphological changes in the two bacterial species, its different effect on cell viability prompted an investigation of the role and function of PBP 2 in P. aeruginosa.
Identification and characterization of pbpA from Pseudomonas aeruginosa
The nucleotide sequence of pbpA was identified within the P. aeruginosa genome 44 by amino acid sequence alignments using E. coli PBP 2 (NCBI accession no. P08150) as the probe. Whereas two homologues of PBP 3 have been identified in P. aeruginosa, 20, 21 and despite a careful search, the only homologue of PBP 2 on the P. aeruginosa chromosome was identified as ORF PA4003 (NCBI accession no. AAD32230). This ORF codes for 646 amino acid residues which provide hypothetical M r and pI values of 72213 and 7.87, respectively. Its predicted amino acid sequence was found to have 43.1% identity and 74.4% similarity to E. coli PBP 2 ( Figure 1 ). Further analysis of the P. aeruginosa PBP 2 hypothetical sequence using the algorithm PSORTb provided a score of 8.02 as a plasma membrane protein associated with the periplasm, while the DAS, TMPred and TMHMM programs led to the identification of an inside to outside transmembrane helix comprising residues Ile-22 to Arg-38, Val-21 to Arg-38 and Val-21 to Tyr-40, respectively. In addition, SignalP identified a potential transmembrane signal peptide involving residues Arg-20 to Ala-37 but no cleavage site was predicted.
Sequence alignment analysis of the hypothetical P. aeruginosa PBP 2 suggests it would be classified as a class B2 PBP, like E. coli PBP 2. Presumably this P. aeruginosa PBP 2 is a mono-functional enzyme which combines both a membrane-associated n-PB domain with an acyl serine transferase PB domain, as known for its E. coli homologue. 5 Based on this alignment, and the analyses described above, the membrane anchor would involve residues Arg-19 to Ala-37, and the nPB domain would continue to Ser-250 (Figure 1) . The remaining C-terminal sequence of Ile-251 to Gln-652 would constitute the PB domain, with Ser-327 predicted to serve as the catalytic nucleophile for transpeptidation (and penicillin-binding) activity.
Analysis of the PAO1 chromosome immediately upstream and downstream of pbpA indicated that, as with E. coli, the gene is located within a cluster that contains several other genes involved in peptidoglycan metabolism, including rodA ( Figure 3) . RodA has also been demonstrated to be essential for rod-shape morphology in E. coli 45 and it is presumed to interact directly with PBP 2. Interestingly, the PAO1 cluster also contains a gene encoding soluble lytic-transglycosylase B1 (SltB1) which is not present in the respective E. coli cluster.
Cloning of pbpA from P. aeruginosa
Based on its nucleotide sequence, oligonucleotide primers were designed to allow PCR amplification of P. aeruginosa pbpA from genomic DNA and subsequent cloning into the T7-based expression vector pET30a(þ) for fusion of the protein to a His 6 -tag. One construct, designated pACJW2 was transformed into the expression strain E. coli BL21 (lDE3) Codonplus ( pLysS) to give E. coli AC224. Due to difficulties encountered with the production and purification of PBP 2 (described below), a soluble derivative of the protein (named sPBP 2) truncated by 38 amino acids was engineered which lacked the hypothetical membrane anchor located at its N-terminus (Figure 1 ). One clone, designated pACKD16 was subsequently used to overexpress the truncated protein in E. coli BL21 (lDE3) CodonPlus ( pLysS) generating E. coli AC252.
Expression of P. aeruginosa pbpA
Growth of E. coli AC224 in LB at 378C and induction with IPTG led to the over-production of PBP 2-His 6 as detected by SDS-PAGE with Coomassie Brilliant Blue staining and western immunoblotting (Figure 4) . Protein was expressed at a relatively low level, and cell fractionation studies indicated it to be localized to the cytoplasmic membrane fraction, as expected (data not shown). Very little PBP 2-His 6 was found in inclusion bodies, which can sometimes be a problem with membrane proteins such as the HMW PBPs. Growth was allowed to continue for a maximum of 3 h, as this appeared to provide optimal expression. Incubation for longer periods of time resulted in very poor yields which were found to be due to cell lysis suggesting that overexpression of PBP 2 is lethal for the cell.
In contrast to full-length PBP-His 6 , high levels of the truncated sPBP 2-His 6 could be obtained with E. coli AC252 without any apparent impairment of cell growth, even after extended periods of incubation following IPTG induction (data not shown). Most of the protein produced was recovered in the soluble fraction of lysed cells, but some was contained in insoluble protein aggregates.
Purification of PBP 2
Cells of E. coli AC224 overexpressing full-length PBP 2-His 6 were ruptured using a French Press and isolated membranes were solubilized with 2% Sarkosyl. The solubilized cytoplasmic membrane proteins were subjected to affinity chromatography on His-Select agarose and PBP 2-His 6 was eluted using imidazole. Using western immunoblotting with an anti-His antibody, it was found that most of the PBP 2-His 6 did not bind the affinity column but instead was contained in the flow-through fraction (Figure 5a ). Attempts to increase the binding efficiency of PBP 2-His 6 using slower flow rates, decreased buffer and Sarkosyl concentrations, and/or different detergents (octyl-glucoside, CHAPS, Triton X-100) failed. The amount of PBP 2-His 6 that bound the column and was subsequently purified by this method was estimated to be approximately 60 mg.
As noted above, growth and IPTG induction of E. coli AC252 led to the high-level expression of truncated sPBP 2-His 6 . This protein could be subjected to affinity chromatography on His-Select agarose without the use of detergent. sPBP 2-His 6 was recovered from the column with a yield of 800 -1000 mg, more than ten times the amount compared with that of full-length PBP 2-His 6 (Figure 5b ).
Characterization of PBP 2
To ensure that the proteins being investigated were indeed either the full-length or truncated PBP 2 from P. aeruginosa, N-terminal sequence analysis and mass-spectrometry fingerprinting were performed. The N-terminal amino acid sequences obtained corresponded to those expected for each protein (Figure 1) , and the MS-Fit 42 gave a MOWSE score of 3.3 Â 10 7 , thus confirming the identity of P. aeruginosa PBP 2. Both PBP 2-His 6 and sPBP 2-His 6 were assayed for penicillin-binding activity to determine if they remained active Crude preparations of sPBP 2 and its S327A derivative were applied to the affinity matrix in lysis buffer at 48C (lanes 1) and following a wash with lysis buffer containing 10 mM imidazole (lanes 2), the proteins were eluted from the respective columns with lysis buffer containing 250 mM imidazole (lanes 3). Molecular weight markers (kDa) are indicated on the left. SDS-PAGE-based penicillin-binding assays were performed using fluorescent Bocillin FL and biotinylated ampicillin (Biotin-Amp) as described in the Materials and methods section. following their isolation and purification. The purified fulllength PBP 2-His 6 and truncated sPBP 2-His 6 were able to bind both Bocillin FL, a fluorescently labelled penicillin and biotinylated ampicillin ( Figure 5 ), suggesting that the PBPs were functional and apparently not hindered in this capacity by the presence of the C-terminal His-tags.
To confirm the specificity of mecillinam for P. aeruginosa PBP 2, a competition assay was performed. Protein samples were pre-incubated with mecillinam and then subjected to both the fluorescent Bocillin FL-and biotinylated-ampicillin-based PBP assays. As demonstrated in Figure 6 , binding of both Bocillin FL and biotinylated ampicillin was greatly inhibited by this pre-treatment in a concentration-dependent manner, whereas control samples pre-incubated in its absence were readily detected by the assays. Inhibition of the PBP assay was detected with as little as 1.0 mg/L mecillinam, and concentrations greater than 5.0 mg/L virtually abolished the binding of labelled ampicillin.
Engineering of a non-functional mutant of pbpA
The sequence alignment studies described above identified residue 327 of the SxxK consensus sequence as the invariant Ser located in the PB-domain of the P. aeruginosa PBP 2, strongly suggesting its role as the catalytic nucleophile that covalently binds b-lactams. Site-specific replacement of Ser-327 in the truncated sPBP 2 with an Ala residue was achieved using the QuickChange Site-Directed Mutagenesis kit to generate pACDC38. The mutated pbpA gene on pACDC38 was overexpressed in E. coli BL21 (E. coli AC253) and the protein generated was isolated by affinity chromatography on His-Select agarose (Figure 5c ). Although not purified to apparent homogeneity, PBP assays conducted with the Ser-327 ! Ala PBP 2 preparation demonstrated its inability to bind penicillin ( Figure 5) , thus confirming the identification of Ser-327 as the catalytic nucleophile in the PB (transpeptidase) domain.
Generation of a pbpA chromosomal insertion knockout mutant
A chromosomal knockout mutant of pbpA was constructed by inserting a non-polar 1088 bp Gm R cassette within the open reading frame of the chromosomal pbpA gene. A final PCR-based screen was used to verify insertion of the Gm R cassette into the chromosomal copy of pbpA. Template DNA isolated from wild-type cells produced a PCR product of 1994 bp whereas that obtained from insertion mutants produced a PCR product of 3082 bp.
PAO1 DpbpA mutants lacking a functional pbpA gene were observed to grow in LB broth at 378C, albeit at an apparent slower rate compared with wild-type PAO1 cells (Figure 7) . SEM analysis revealed that, like wild-type cells treated with mecillinam, the PAO1 DpbpA mutant grows with a spherical morphology, although perhaps with a little less uniformity in appearance (Figure 7) . Normal rod-shaped morphology and cell dimensions were restored upon transformation of the mutant with the complementation vector pACBL31 which contained a functional copy of pbpA. However, complementation of the PAO1 DpbpA mutant with pACBL34 harbouring the inactive Ser-327 ! Ala PBP 2 derivative did not result in the restoration of wild-type cell morphology (data not shown).
The MIC values of a select group of b-lactams, including the anti-pseudomonal antibiotics carbenicillin, cefotaxime and ticarcillin, for the different P. aeruginosa strains are presented in Table 2 . As expected, wild-type P. aeruginosa PAO1 was relatively resistant to amoxicillin, ampicillin, cefoxitin and cefalotin while it was susceptible to the anti-pseudomonal b-lactams carbenicillin, cefotaxime and ticarcillin. Interestingly, the PAO1 DpbpA mutant was significantly more susceptible to each of these b-lactams. For the anti-pseudomonal compounds, the MICs were lower by approximately one order of magnitude while the values for the other b-lactams were decreased by one to two orders of magnitude. As observed with the morphological phenotype, complementation of the insertional mutant with a functional copy of pbpA restored wild-type levels of the MIC values for these antibiotics.
Analysis of peptidoglycan
With the PBPs being responsible for the final stages of peptidoglycan biosynthesis, a comparison of the peptidoglycans isolated from wild-type PAO1 grown in the absence and presence of 200 mg/L mecillinam with that of the insertional pbpA mutant cells was made. As expected, the overall compositional analysis of the peptidoglycans was the same and consistent with the A1g chemotype involving a stem peptide containing diaminopimelic acid (DAP) (data not shown). Muropeptide maps generated by analytical HPLC indicated that the overall distribution of the mutanolysin-derived oligomuropeptides was very similar for the three preparations (data not shown). Total cross-linking was determined based on these analyses and, unlike the situation with E. coli, 46 only a slight increase was observed in the peptidoglycan synthesized in the presence of mecillinam compared with that obtained from untreated cells (32.8% and 28.4%, respectively). Likewise, a similar level of 29.5% cross-linking was present in the peptidoglycan from the PAO1 DpbpA mutant.
Discussion
Previous studies had demonstrated that P. aeruginosa is resistant to the b-lactam antibiotic mecillinam, 10, 16, 17 a finding confirmed in the current investigation. This resistance was postulated to result from decreased entry of the antibiotic into the periplasm, conversion of rod-shaped cells into spherical cells) clearly indicates that it is able to reach its target and affect peptidoglycan synthesis. Indeed, the resulting morphological changes preclude the possibility that the AmpC b-lactamase encoded on the P. aeruginosa chromosome serves as the resistance factor because its activity would have rendered the hydrolysed mecillinam incapable of covalently binding to, and thereby inactivating, its target PBP. Likewise, efflux pumps can be excluded. This resistance thus suggested that, unlike the situation with E. coli, 15,48 the target of mecillinam in P. aeruginosa is not essential for its viability.
Earlier investigations involving whole cell preparations of P. aeruginosa had shown that its class B HMW PBP 2 is the target of mecillinam. 17, 49 In this study, we demonstrated that PA4003 encodes PBP 2 and that it does indeed bind mecillinam covalently and with specificity. The consequent generation of spherical cells caused by mecillinam inhibition or insertional mutation of PBP 2 indicates that, like E. coli, the function of PBP 2 in P. aeruginosa relates directly to the biosynthesis and maintenance of the cylindrical wall in the peptidoglycan sacculus. Our ability to generate the viable insertional mutant is consistent with our proposal that PBP 2 is non-essential to P. aeruginosa. This distinguishing property could be accounted for if the bacterium produces a second PBP 2 homologue with reduced affinity for the b-lactam in a manner analogous to the methicillin-resistant strains of Staphylococcus aureus which produce a second form of its PBP 2 (PBP 2a). Indeed, such a possibility is conceivable given that the genome size of P. aeruginosa is approximately double that of E. coli, and it is known that P. aeruginosa does encode and produce two homologues of PBP 3 20, 21 in contrast to only one in E. coli. However, an extensive and careful search of the P. aeruginosa genome failed to find any evidence of a second copy of PBP 2. Likewise, a second P. aeruginosa PBP 2 homologue has not been detected experimentally using SDS-PAGE-based assays, 22 a finding we have confirmed (data not presented).
The difference between the activities of PBPs 2 and 3 is thought to be caused by differences in substrate specificity, with PBP 2 requiring pentapeptide stem peptides to function while PBP 3 prefers tripeptide side chains for optimal activity. 50, 51 Unfortunately, the enzymatic properties of PBP 3x from P. aeruginosa have not been characterized, but it is conceivable the specificity of its transpeptidase domain is less stringent than PBP 3 thereby providing a compensatory activity for PBP 2 to retain the cells in a viable state, a phenomenon referred to as 'equivalent substitution'. 52 The observation that the average level of peptidoglycan cross-linking was similar for both the wild-type and mutant strains does suggest that at least one of the other HMW PBPs (namely PBP 3x and/or 1a, 1b and 3) accommodates for the loss of some transpeptidase activity associated with PBP 2. However, it is clear that the activity of these other HMW PBPs does not substitute for PBP 2 in the maintenance of the cylindrical Figure 7 . Growth and morphology of P. aeruginosa strains. Overnight cultures of (filled circles) PAO1 and (open circles) PAO1-DpbpA in LB broth were used to inoculate fresh LB at 378C and growth was monitored by optical density measurements made at 600 nm. Samples of (a) PAO1-DpbpA and (b) P. aeruginosa PAO1-DpbpA harbouring the complementation plasmid pACBL31 grown to mid-exponential phase were recovered and prepared for SEM. The solid bars denote 1 mm. cell wall. That the transpeptidase activity associated with PBP 2 is normally required for this purpose was unequivocally demonstrated by the inability of the plasmid harbouring the inactive Ser-237 ! Ala PBP 2 to complement the morphological change associated with the PAO1 DpbpA insertional mutant. In addition to providing compensation for the lack of PBP 2 in P. aeruginosa, equivalent substitution also appears to contribute to b-lactam resistance involving the activity of this PBP. Cells lacking a functional copy of pbpA were observed to be significantly more susceptible to a variety of different b-lactams, including those not considered to be anti-pseudomonal such as ampicillin. Indeed, the MIC of this b-lactam for wild-type PAO1 was observed to decrease from over 3200 mg/L to 25 mg/ L upon the insertional mutation of pbpA. These data suggest that P. aeruginosa PBP 2 is relatively unsusceptible to these b-lactams and that, in both wild-type PAO1 and the DpbpA insertional mutant harbouring pACBL31, the functional PBP 2 may provide the equivalent substitution for the other more susceptible PBPs that become inactivated. While more detailed studies are required, these preliminary findings do demonstrate the significance of PBP 2 to P. aeruginosa and suggest that it may represent an important specific target for the development of new antibiotics.
A second major distinction between P. aeruginosa and E. coli in the effect of inactivating PBP 2 concerns the size of the resulting cells which may, in fact, account for the continued viability of P. aeruginosa. That cells of P. aeruginosa lacking PBP 2 activity retain their original diameter is significant because the cell circumference represents an important factor for the process of cell division. The formation of the Z ring that has to extend around the complete circumference of a cell at its site of division requires both a critical concentration of FtsZ and appropriate proportions of the associated Z-ring stabilizing and destabilizing proteins (Figure 8 ). For this to occur, the division proteins are produced in both constant and balanced concentrations sufficient to maintain normal morphology (recently reviewed in ref. 53) . In view of this, it has been proposed that the ever-enlarging spherical cells of E. coli lacking a functioning PBP 2 would have insufficient concentrations of these proteins to generate a complete Z ring, thus precluding their ability to divide and leading to their consequent death. This hypothesis is supported by studies demonstrating that inactivation of PBP 2 in E. coli is permitted conditional upon overexpression of the cell division proteins FtsZ, FtsA and FtsQ, either directly in engineered mutants 11, 15 or indirectly by increasing ppGpp concentrations. 11, 13, 48 Whereas considerably less is known about the division process in P. aeruginosa, an analysis of its Mra operon suggests the clustering of fts and mur genes with an arrangement remarkably similar to that on the E. coli chromosome. 54, 55 Hence, it is generally assumed that division proceeds similarly to the process known for E. coli. Given this, the fact that the circumference of P. aeruginosa cells lacking a functioning PBP 2 does not significantly increase would permit complete Z rings to form thereby allowing their continued division. Why the diameter of P. aeruginosa lacking a functional PBP 2 does not change remains unknown, and given the complexity of both peptidoglycan structure and metabolism, it may prove extremely difficult to determine. Figure 8 . Division of E. coli and P. aeruginosa involving the formation of the Z ring composed of the cell division protein FtsZ. A: In wild-type cells of either E. coli or P. aeruginosa, the Z ring encircles their circumference at their mid-point to initiate division. B: Following the inactivation of PBP 2 in E. coli by either treatment with mecillinam or mutation, cells enlarge and the concentration of FtsZ is insufficient to create a complete Z ring thus precluding their ability to divide and leads to autolysis. C: Inactivation of P. aeruginosa PBP 2 does not result in their increased diameter allowing a closed Z ring to form and consequent division to occur.
Another significant finding of this study pertains to our observation that reproducing spherical cells of P. aeruginosa are capable of reversion back to rod shape morphology upon removal of inhibiting mecillinam. A model proposed for the propagation of the cylindrical wall region in E. coli invokes a strand of an existing peptidoglycan chain to serve as a guide and template for the biosynthetic complex of enzymes. 56 This complex was thus proposed to copy the existing sacculus to transmit the shape from one generation to the next. However, the apparent capability of P. aeruginosa to revert back to its normal rod shape is in contradiction to this model, at least as it might apply to this bacterium. This view is further supported by our ability to complement the insertional genomic pbpA mutant (which grow and reproduce as cocci) with a functional copy of pbpA to restore the normal rod-shaped morphology. These observations clearly indicate that cell morphology as directed by the peptidoglycan sacculus is not dependent on any pre-existing structure to function as a template.
More recent studies with E. coli have demonstrated the relationship between FtsZ and cell shape extends to include the 'cytoskeletal' proteins MreB, MreC and MreD. A mutual interdependency between the formation of the MreB cables that extend below the cytoplasmic membrane and cell shape has been proposed. 57 Interestingly, depletion of any one of these cytoskeletal proteins also leads to the formation of large spherical cells which eventually lyse. As with PBP 2 inactivation, this effect is likewise suppressed by overexpression of the FtsQAZ proteins. These morphogenic MreBCD proteins were shown to form a multi-protein, transmembrane complex with RodA and PBP 2 to direct longitudinal cell wall synthesis. 57, 58 With P. aeruginosa, our preliminary studies have indicated that a multi-protein complex involving PBP 2 also forms. 59 This, together with the observations that pbpA encoding PBP 2 is clustered similarly with the rodA gene as on E. coli chromosome and that the mreB, mreC and mreD genes are arranged identically, would suggest that a similar interplay between PBP 2 and the MreBCD proteins might exist in P. aeruginosa. Hence, our findings tend to support the proposal that a morphogenic apparatus associated with peptidoglycan metabolism and not preexisting structure is fully responsible for shape determination. However, delineating the true composition and mechanism of action of this putative morphogenic apparatus will certainly prove to be challenging recognizing that most of the proteins associated with it are membrane-bound, and they function on a totally insoluble complex heteropolymer. Given the clinical relevance of P. aeruginosa, it is possible that our understanding of its differences compared with the 'model' E. coli bacterium will be important for future approaches in antibacterial therapy.
